Navigation Links
Venaxis to Present at Three Upcoming Investor Conferences
Date:9/5/2013

e not guarantees of future performance. Actual results or developments may differ materially from those projected in the forward-looking statements as a result of many factors, including our ability to successfully complete required product development and modifications in a timely and cost effective manner, complete clinical trial activities for the APPY1 Test required for FDA submission, obtain FDA clearance or approval, maintain CE Marking, cost effectively manufacture and generate revenues from the APPY1 Test at a profitable price point, execute agreements required to successfully advance the company's objectives, retain the management team to advance the products, overcome adverse changes in market conditions and the regulatory environment, obtain and enforce intellectual property rights, and realize value of intangible assets. Furthermore, Venaxis does not intend (and is not obligated) to update publicly any forward-looking statements. The contents of this press release should be considered in conjunction with the risk factors contained in Venaxis' recent filings with the SEC, including its Form 10-Q for the quarter ended June 30, 2013.

For Investors and Media:
Tiberend Strategic Advisors, Inc.

Joshua Drumm, PhD 
jdrumm@tiberend.com; (212) 375-2664

Claire Sojda 
csojda@tiberend.com; (212) 375-2686


'/>"/>
SOURCE Venaxis, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Venaxis to Present at Canaccord Genuity 33rd Annual Growth Conference
2. Venaxis Appoints SomaLogic CMO and former Pfizer Executive Stephen A. Williams, M.D., Ph.D., to Board of Directors
3. Venaxis Advances Pivotal U.S. Study and Accelerates European Market Development for APPY1 Blood-based Appendicitis Test
4. Venaxis to Present at 25th Annual ROTH Conference
5. Venaxis Presentation Rescheduled for 2013 BIO CEO and Investor Conference
6. Venaxis to Present at 2013 BIO CEO and Investor Conference
7. AspenBio Pharma Changes Company Name to Venaxis, Inc.
8. Soligenix to Present at the 15th Annual Rodman & Renshaw Global Investment Conference in New York City
9. Isis Pharmaceuticals to Present at the 2013 Stifel Healthcare Conference
10. Lexicon To Present At The Morgan Stanley Global Healthcare Conference
11. Cadence Pharmaceuticals CEO Ted Schroeder To Present At The Stifel Nicolaus Healthcare Conference 2013 On September 11, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... 1, 2015 Konica Minolta Medical Imaging announced ... system, designed to deliver enterprise level imaging to community ... Control Station as the Konica Minolta AeroDR wireless flat ... path from CR to DR. The SIGMA II CS-7s ... workflow with unparalleled reliability and high capacity to help ...
(Date:9/1/2015)... PHILADELPHIA , Sept. 1, 2015 ... in sleep therapy, and HGE Health Care Solutions, ... management, announced today a comprehensive sleep management and ... Apnea (OSA). OSA is a chronic ... during sleep and may increase a patient,s risk ...
(Date:9/1/2015)... Conn. , Sept. 1, 2015  Results from ... AD™ study demonstrate that 5g of idarucizumab enabled ... situations involving patients treated with dabigatran (Pradaxa ® ... of the anticoagulant effect of dabigatran enabled patients ... a median time of 1.7 hours between administration ...
Breaking Medicine Technology:Konica Minolta Launches New CR System with Low-Cost Upgrade Path to DR 2Sleep Specialists, LLC and HGE Health Care Solutions Announce Comprehensive Sleep Program 2New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 2New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 3New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 4New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 5New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 6New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 7New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 8New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 9
... 11, 2012   Cerecor Inc. , a biopharmaceutical company ... pharmaceuticals whose primary activity is in the human nervous ... Application for FP01 for the treatment of cough has ... Food and Drug Administration (FDA).  The Company plans to ...
... responsibilities of being a pet owner is to guard ... While many people treat their pets with monthly preventative ... actually work. In honor of National Heartworm Awareness Month, ... safety measures for keeping pets heartworm free.  ...
Cached Medicine Technology:Cerecor Announces Clearance of IND for FP01 2petMD.com Celebrates Heartworm Awareness Month with Five Heartworm Prevention Tips for Pet Owners 2petMD.com Celebrates Heartworm Awareness Month with Five Heartworm Prevention Tips for Pet Owners 3
(Date:9/2/2015)... (PRWEB) , ... September 02, 2015 , ... ... September as Brain Aneurysm Awareness Month , which was established by the ... , “Spreading awareness and education, and helping fund more research remains our top ...
(Date:9/2/2015)... ... September 02, 2015 , ... This Fall, as ... (BCAM), Bright Pink, a national non-profit focused on the prevention and early detection ... a campaign to educate women to be breast and ovarian self-aware and celebrate ...
(Date:9/1/2015)... CA (PRWEB) , ... September 01, 2015 , ... ... Business Times discusses the hundreds of thousands of plastic surgeries conducted each year ... and reality TV for the growing numbers. Beverly Hills-based plastic surgeon Payam Jarrah-Nejad, ...
(Date:9/1/2015)... ... September 01, 2015 , ... The Capillus82™ ... treatment of androgenic alopecia in adults, announces Miami-based medical device manufacturer, Capillus, LLC. ... also demonstrating its safety when used at home to combat hair loss. ...
(Date:9/1/2015)... ... September 01, 2015 , ... ProRehab Physical Therapy , ... partnership with Apex Physical Therapy (Apex) is official as of August ... compassionate, and empathetic care to local residents from their combined eight locations throughout ...
Breaking Medicine News(10 mins):Health News:September Celebrated as Brain Aneurysm Awareness Month 2Health News:Bright Pink Launches Act On Facts™, A Campaign To Empower Young Women To Take Action Related To Their Breast And Ovarian Health 2Health News:Bright Pink Launches Act On Facts™, A Campaign To Empower Young Women To Take Action Related To Their Breast And Ovarian Health 3Health News:Teen Plastic Surgery Article Understates the Most Important Realities of Procedures on Young People, Notes Dr. J 2Health News:Capillus82™ Laser Therapy Cap Receives FDA Clearance for Treatment of Hair Loss 2Health News:ProRehab Physical Therapy Partnership with Apex Physical Therapy Now Official 2Health News:ProRehab Physical Therapy Partnership with Apex Physical Therapy Now Official 3
... Safety Project Report Makes Recommendations for System in Critical Need ... Nov. 17 Weaknesses in food safety policy, organization and ... Saintpaul, according to a report released today by the Produce ... at Georgetown University . , ...
... MYL ) today announced that its subsidiary, Mylan ... Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) ... , Fluoxetine Capsules, indicated for ... version of Eli Lilly,s Sarafem(R) Pulvules(R) Capsules. This product had ...
... procedure in which her stem cells were combined with ... , , TUESDAY, Nov. 18 (HealthDay News) -- In a ... undergone the first transplantation of a breathing passage fashioned ... researchers report. , As of now, the woman, Claudia ...
... as Chairman, Tony Strange Appointed to CEO position and Will ... , MELVILLE, N.Y., Nov. 18 /PRNewswire-FirstCall/ ... ), a leading provider of comprehensive home health services, announced ... succession plan. Effective January 1, 2009, Tony Strange will ...
... and Policy Center (NLPC), a plaintiff in the successful 1993 ... Clinton,s health care task force, today criticized Barack Obama for ... , According to NLPC President Peter ... General. His track record is not one of independence or ...
... mechanisms, scientists show , , TUESDAY, Nov. 18 (HealthDay News) ... mechanisms, according to a Washington University study that challenges ... version of the body,s response to pain. , This ... itching and pain. , Zhou-Feng Chen, of Washington University,s ...
Cached Medicine News:Health News:Salmonella Saintpaul Outbreak Exposes Food Safety Weaknesses 2Health News:Salmonella Saintpaul Outbreak Exposes Food Safety Weaknesses 3Health News:Airway Transplant Aided by Stem Cells a Medical First 2Health News:Airway Transplant Aided by Stem Cells a Medical First 3Health News:Gentiva Health Services Confirms Management Succession 2Health News:Gentiva Health Services Confirms Management Succession 3Health News:Gentiva Health Services Confirms Management Succession 4Health News:NLPC Criticizes Obama's Choice of Eric Holder for Attorney General Because of Role in Health Care Task Force Cover-Up 2Health News:Itching Not a Less Intense Form of Pain 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: